What are the diagnostic criteria and treatment approaches for essential (primary) hypertension versus secondary hypertension?

Essential (Primary) vs Secondary Hypertension: Diagnostic Criteria and Treatment

Essential hypertension accounts for 95% of all hypertension cases and is diagnosed by exclusion after ruling out identifiable secondary causes, while secondary hypertension requires targeted investigation when clinical clues suggest specific underlying pathology—treatment differs fundamentally as secondary forms may be curable with cause-specific interventions whereas essential hypertension requires lifelong pharmacotherapy and lifestyle modification 1, 2.

Diagnostic Differentiation

Essential Hypertension Diagnosis

Essential hypertension is defined as BP ≥130/80 mm Hg (or ≥140/90 mm Hg by traditional criteria) confirmed on multiple occasions without an identifiable underlying cause 2, 3. This represents the default diagnosis after excluding secondary causes 4.

Key diagnostic steps:

• Confirm hypertension with standardized BP measurement technique and out-of-office monitoring (home or ambulatory BP) to exclude white coat hypertension 3, 5
• Rule out secondary causes through targeted screening (see below)
• Document absence of specific clinical features suggesting secondary forms

When to Suspect Secondary Hypertension

Screen aggressively for secondary causes when:

• Age of onset <30 years or >60 years with new-onset hypertension
• Resistant hypertension (BP uncontrolled despite 3 optimal-dose medications including a diuretic) 1, 5
• Severe hypertension (BP ≥180/120 mm Hg)
• Acute BP elevation in previously controlled patients
• Target organ damage disproportionate to hypertension duration 6, 7

Most Common Secondary Causes to Evaluate

Primary aldosteronism is the most common secondary cause and should be screened in resistant hypertension cases 1, 6. Look for:

• Hypokalemia (though often normokalemic)
• Resistant hypertension
• Screening: aldosterone-to-renin ratio

Renovascular hypertension presents with 1:

• Abdominal bruit
• Flash pulmonary edema
• Acute kidney injury with ACE inhibitor/ARB initiation
• Asymmetric kidney sizes on imaging

Obstructive sleep apnea 6:

• Obesity, loud snoring, witnessed apneas
• Daytime somnolence
• Resistant hypertension pattern

Drug-induced hypertension 6:

• NSAIDs, decongestants, oral contraceptives, corticosteroids
• Stimulants, illicit drugs (cocaine, amphetamines)
• Licorice, herbal supplements

Treatment Approaches

Essential Hypertension Treatment

Pharmacotherapy algorithm 1, 2, 3:

1. Stage 1 hypertension (130-139/80-89 mm Hg): Start single agent if ASCVD risk ≥10% or existing CVD; otherwise lifestyle modification alone

2. Stage 2 hypertension (≥140/90 mm Hg): Initiate 2-drug combination from different classes 2

First-line medication classes (choose based on patient factors) 2:

• Thiazide/thiazide-like diuretics
• ACE inhibitors
• Angiotensin receptor blockers (ARBs)
• Dihydropyridine calcium channel blockers (CCBs)

Preferred initial combinations 2:

• ACE inhibitor or ARB + thiazide diuretic
• ACE inhibitor or ARB + CCB
• CCB + thiazide diuretic

Critical caveat: Never combine ACE inhibitor + ARB + renin inhibitor—this is potentially harmful 2.

Target BP: <130/80 mm Hg for most patients 3, 8

Resistant hypertension management 1:

• Confirm true resistance (exclude non-adherence, white coat effect, suboptimal dosing)
• Ensure regimen includes appropriate thiazide diuretic at optimal dose
• Add spironolactone 25-50 mg daily as fourth agent (Class IIa recommendation) 1
• If spironolactone not tolerated: consider eplerenone, beta-blocker (if not already used), or centrally acting agent 1

Secondary Hypertension Treatment

The fundamental principle: Treat the underlying cause first, as this may cure or substantially improve hypertension 1, 6.

Primary aldosteronism 1:

• Unilateral disease: Surgical adrenalectomy (curative in appropriate candidates)
• Bilateral disease: Medical therapy with mineralocorticoid receptor antagonists
  • Spironolactone 50-100 mg daily, titrate up to 300-400 mg if needed
  • Eplerenone alternative (less gynecomastia/erectile dysfunction but less potent)
• Distinguish unilateral vs bilateral with adrenal vein sampling

Renovascular hypertension 1:

• Fibromuscular dysplasia: Percutaneous transluminal renal angioplasty (PTRA) without stenting is treatment of choice
• Atherosclerotic disease: Medical therapy first-line; RAS blockers preferred but monitor renal function closely
• Revascularization reserved for specific indications (flash pulmonary edema, progressive renal dysfunction)

Obstructive sleep apnea 6:

• CPAP therapy
• Weight loss
• Positional therapy
• Continue antihypertensive medications as BP often remains elevated despite OSA treatment

Drug-induced hypertension 6:

• Discontinue offending agent when possible
• Switch to alternative medications
• If discontinuation not feasible, intensify antihypertensive therapy

Critical Clinical Pitfalls

Common diagnostic errors:

• Failing to confirm hypertension with out-of-office measurements before initiating treatment 3, 5
• Missing secondary causes in young patients or those with resistant hypertension 7
• Inadequate screening for medication non-adherence before labeling as resistant 5

Treatment mistakes:

• Using suboptimal medication doses or non-preferred agents 5
• Combining drugs with similar mechanisms (e.g., two drugs from same class) 2
• Delaying diagnosis of secondary hypertension due to vascular remodeling, which reduces cure rates 1
• Not recognizing that early diagnosis of secondary hypertension dramatically improves cure rates 1

The timing imperative: Secondary hypertension diagnosed early has higher cure rates; delayed diagnosis leads to irreversible vascular remodeling that perpetuates hypertension even after treating the underlying cause 1.